OptimizeRx Corp. (OPRX)

9.73
NASDAQ : Technology Services
Prev Close 9.65
Day Low/High 9.62 / 9.80
52 Wk Low/High 8.92 / 17.24
Avg Volume 116.70K
Exchange NASDAQ
Shares Outstanding 14.54M
Market Cap 140.32M
P/E Ratio N/A
Div & Yield N.A. (N.A)
OptimizeRx Reports Third Quarter 2019 Results

OptimizeRx Reports Third Quarter 2019 Results

ROCHESTER, Mich., Nov.

OptimizeRx Becomes Oversold (OPRX)

OptimizeRx Becomes Oversold (OPRX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

OptimizeRx Launches Newly Integrated Platform To Improve Outcomes

OptimizeRx Launches Newly Integrated Platform To Improve Outcomes

ROCHESTER, Mich., Oct.

OptimizeRx To Participate At Investor Conferences In November

OptimizeRx To Participate At Investor Conferences In November

ROCHESTER, Mich., Oct.

OptimizeRx Sponsors WOMEN At HLTH Program At The 2019 HLTH Conference

OptimizeRx Sponsors WOMEN At HLTH Program At The 2019 HLTH Conference

ROCHESTER, Mich., Oct.

OptimizeRx Enters Oversold Territory (OPRX)

OptimizeRx Enters Oversold Territory (OPRX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

OptimizeRx To Acquire Digital Therapeutics SaaS Platform Provider, RMDY Health

OptimizeRx To Acquire Digital Therapeutics SaaS Platform Provider, RMDY Health

Acquisition to Enhance OptimizeRx Existing Digital Platform with Technology Solutions Tailored for Digital Therapeutics; Extends Offerings to SaaS-based Patient Engagement Markets

OptimizeRx Sets Second Quarter 2019 Conference Call For Wednesday, August 7, 2019 At 4:30 P.m. ET

OptimizeRx Sets Second Quarter 2019 Conference Call For Wednesday, August 7, 2019 At 4:30 P.m. ET

ROCHESTER, Mich., July 24, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp.

OptimizeRx Establishes Direct Partnership And Integration With NextGen Healthcare

OptimizeRx Establishes Direct Partnership And Integration With NextGen Healthcare

More Than 55,000 Prescribers on the NextGen® Enterprise Network Will Have Immediate Access to OptimizeRx's Point-of-Care Platform That Links the Pharma-Physician-Patient-Payor Continuum

OptimizeRx Is Now Oversold (OPRX)

OptimizeRx Is Now Oversold (OPRX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Oversold Conditions For OptimizeRx (OPRX)

Oversold Conditions For OptimizeRx (OPRX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BPT, BRT, CALL, CVM, GCI, OCC, SNMP, WCFB, WYY Downgrades: CERC, IESC Initiations: GRNQ, OPRX Read on to get TheStreet Quant Ratings' detailed report:

TheStreet Quant Rating: C (Hold)